12-39951309-C-A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_052885.4(SLC2A13):​c.982G>T​(p.Val328Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000341 in 1,611,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

SLC2A13
NM_052885.4 missense

Scores

3
3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.94

Publications

0 publications found
Variant links:
Genes affected
SLC2A13 (HGNC:15956): (solute carrier family 2 member 13) Enables ATPase binding activity; myo-inositol:proton symporter activity; and protease binding activity. Involved in myo-inositol transport and positive regulation of amyloid-beta formation. Is integral component of plasma membrane. Part of cell body; cell periphery; and cell projection. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.32329106).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC2A13NM_052885.4 linkc.982G>T p.Val328Leu missense_variant Exon 4 of 10 ENST00000280871.9 NP_443117.3 Q96QE2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC2A13ENST00000280871.9 linkc.982G>T p.Val328Leu missense_variant Exon 4 of 10 1 NM_052885.4 ENSP00000280871.4 Q96QE2
SLC2A13ENST00000380858.1 linkc.982G>T p.Val328Leu missense_variant Exon 4 of 4 1 ENSP00000370239.1 E9PE47

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
151842
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000508
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000519
AC:
13
AN:
250284
AF XY:
0.0000222
show subpopulations
Gnomad AFR exome
AF:
0.000556
Gnomad AMR exome
AF:
0.0000584
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000883
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000233
AC:
34
AN:
1460004
Hom.:
0
Cov.:
30
AF XY:
0.0000207
AC XY:
15
AN XY:
726308
show subpopulations
African (AFR)
AF:
0.000689
AC:
23
AN:
33404
American (AMR)
AF:
0.0000674
AC:
3
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39590
South Asian (SAS)
AF:
0.0000465
AC:
4
AN:
85990
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53378
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1110970
Other (OTH)
AF:
0.0000332
AC:
2
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
151842
Hom.:
0
Cov.:
32
AF XY:
0.000135
AC XY:
10
AN XY:
74114
show subpopulations
African (AFR)
AF:
0.000508
AC:
21
AN:
41322
American (AMR)
AF:
0.00
AC:
0
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10518
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67974
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000988
Hom.:
0
Bravo
AF:
0.000159
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.00
EpiControl
AF:
0.0000595

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 15, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.982G>T (p.V328L) alteration is located in exon 4 (coding exon 4) of the SLC2A13 gene. This alteration results from a G to T substitution at nucleotide position 982, causing the valine (V) at amino acid position 328 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.14
T;T
Eigen
Benign
-0.039
Eigen_PC
Benign
0.18
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.97
D;D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.32
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.19
N;.
PhyloP100
6.9
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.17
Sift
Benign
0.37
T;T
Sift4G
Benign
0.46
T;T
Polyphen
0.016
B;B
Vest4
0.83
MutPred
0.65
Gain of helix (P = 0.132);Gain of helix (P = 0.132);
MVP
0.60
MPC
0.30
ClinPred
0.041
T
GERP RS
5.2
Varity_R
0.22
gMVP
0.74
Mutation Taster
=34/66
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748960640; hg19: chr12-40345111; API